Bay Area's Rani Therapeutics Lands $53M as Company Moves to Clinical Trials Post author:Sam Post published:February 7, 2018 Post category:BioPharma Rani said the latest funding round brings its coffers a total of $142M. Source: BioSpace You Might Also Like Sangamo, Pfizer Deepen Relationship With New $162M ALS R&D Pact January 2, 2018 <b>Lexington Biosciences</b> Introduces President And Board Chair May 25, 2017 Novartis' Bet Pays Off as Advanced Accelerator Applications Wins FDA Nod for Lutathera January 25, 2018
Novartis' Bet Pays Off as Advanced Accelerator Applications Wins FDA Nod for Lutathera January 25, 2018
